pharmaceuticals-and-healthcare

EMEA (Europe, Middle East and Africa) Influenza Vaccine Market Report 2017


Published On : Jun 2017

Category : Pharmaceutical

No. of Pages : 119 pages

  • $4000
  • $8000

Please click below to avail discount on this report

In this report, the EMEA Influenza Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Influenza Vaccine for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Influenza Vaccine market competition by top manufacturers/players, with Influenza Vaccine sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including
GSK
Sinovac
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
Tasly&Jenner
Tiantan

On the basis of product, this report displays the sales volume (K Doses), revenue (Million USD), product price (USD/Dose), market share and growth rate of each type, primarily split into
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Doses), market share and growth rate of Influenza Vaccine for each application, including
Children
Adults
Elderly
Pregnancy

If you have any special requirements, please let us know and we will offer you the report as you want.

In the recent times, the global market for Emea europe middle east and africa influenza vaccine market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Emea europe middle east and africa influenza vaccine market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Emea europe middle east and africa influenza vaccine market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the Emea europe middle east and africa influenza vaccine market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Emea europe middle east and africa influenza vaccine market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Emea europe middle east and africa influenza vaccine market report 2017, including the definition, classification, and industry chain structure of Emea europe middle east and africa influenza vaccine market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Emea europe middle east and africa influenza vaccine market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Emea europe middle east and africa influenza vaccine market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Emea europe middle east and africa influenza vaccine market report 2017, implemented in each of the geographical segments. The predominant applications of the Emea europe middle east and africa influenza vaccine market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Emea europe middle east and africa influenza vaccine market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Emea europe middle east and africa influenza vaccine market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Influenza Vaccine
Figure EMEA Influenza Vaccine Sales Volume (K Doses) by Type (2012-2022)
Figure EMEA Influenza Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Trivalent Influenza Vaccine Product Picture
Figure Quadrivalent Influenza Vaccine Product Picture
Figure Other Product Picture
Figure EMEA Influenza Vaccine Sales Volume (K Doses) by Application (2012-2022)
Figure EMEA Sales Market Share of Influenza Vaccine by Application in 2016
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Elderly Examples
Table Key Downstream Customer in Elderly
Figure Pregnancy Examples
Table Key Downstream Customer in Pregnancy
Figure EMEA Influenza Vaccine Market Size (Million USD) by Region (2012-2022)
Figure Europe Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Influenza Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Influenza Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Influenza Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Influenza Vaccine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Influenza Vaccine Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table EMEA Influenza Vaccine Sales Volume (K Doses) of Major Players (2012-2017)
Table EMEA Influenza Vaccine Sales Share by Players (2012-2017)
Figure 2016 Influenza Vaccine Sales Share by Players
Figure 2017 Influenza Vaccine Sales Share by Players
Figure EMEA Influenza Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Influenza Vaccine Revenue (Million USD) by Players (2012-2017)
Table EMEA Influenza Vaccine Revenue Share by Players (2012-2017)
Table 2016 EMEA Influenza Vaccine Revenue Share by Players
Table 2017 EMEA Influenza Vaccine Revenue Share by Players
Table EMEA Influenza Vaccine Sale Price (USD/Dose) by Players (2012-2017)
Table EMEA Influenza Vaccine Sales (K Doses) and Market Share by Type (2012-2017)
Table EMEA Influenza Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Influenza Vaccine by Type (2012-2017)
Figure EMEA Influenza Vaccine Sales Market Share by Type (2012-2017)
Table EMEA Influenza Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Influenza Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Influenza Vaccine by Type in 2016
Table EMEA Influenza Vaccine Sale Price (USD/Dose) by Type (2012-2017)
Table EMEA Influenza Vaccine Sales (K Doses) and Market Share by Application (2012-2017)
Table EMEA Influenza Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Influenza Vaccine by Application (2012-2017)
Figure EMEA Influenza Vaccine Sales Market Share by Application in 2016
Table EMEA Influenza Vaccine Sales (K Doses) and Market Share by Region (2012-2017)
Table EMEA Influenza Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Influenza Vaccine by Region (2012-2017)
Figure EMEA Influenza Vaccine Sales Market Share in 2016
Table EMEA Influenza Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Influenza Vaccine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Influenza Vaccine by Region (2012-2017)
Figure EMEA Influenza Vaccine Revenue Market Share Regions in 2016
Table EMEA Influenza Vaccine Sales Price (USD/Dose) by Region (2012-2017)
Figure Europe Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Europe Influenza Vaccine Revenue and Growth Rate (2012-2017)
Table Europe Influenza Vaccine Sales (K Doses) by Type (2012-2017)
Table Europe Influenza Vaccine Market Share by Type (2012-2017)
Figure Europe Influenza Vaccine Market Share by Type in 2016
Table Europe Influenza Vaccine Sales (K Doses) by Application (2012-2017)
Table Europe Influenza Vaccine Market Share by Application (2012-2017)
Figure Europe Influenza Vaccine Market Share by Application in 2016
Table Europe Influenza Vaccine Sales (K Doses) by Countries (2012-2017)
Table Europe Influenza Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Influenza Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Influenza Vaccine Sales Market Share by Countries in 2016
Table Europe Influenza Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Europe Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Influenza Vaccine Revenue Market Share by Countries in 2016
Figure Germany Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure France Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure UK Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Russia Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Italy Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Benelux Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Influenza Vaccine Sales (K Doses) by Type (2012-2017)
Table Middle East Influenza Vaccine Market Share by Type (2012-2017)
Figure Middle East Influenza Vaccine Market Share by Type (2012-2017)
Table Middle East Influenza Vaccine Sales (K Doses) by Applications (2012-2017)
Table Middle East Influenza Vaccine Market Share by Applications (2012-2017)
Figure Middle East Influenza Vaccine Sales Market Share by Application in 2016
Table Middle East Influenza Vaccine Sales Volume (K Doses) by Countries (2012-2017)
Table Middle East Influenza Vaccine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Influenza Vaccine Sales Volume Market Share by Countries in 2016
Table Middle East Influenza Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Influenza Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Israel Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure UAE Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Iran Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Influenza Vaccine Sales (K Doses) by Type (2012-2017)
Table Africa Influenza Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Influenza Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Influenza Vaccine Sales Market Share by Type in 2016
Table Africa Influenza Vaccine Sales (K Doses) by Application (2012-2017)
Table Africa Influenza Vaccine Sales Market Share by Application (2012-2017)
Figure Africa Influenza Vaccine Sales Market Share by Application (2012-2017)
Table Africa Influenza Vaccine Sales Volume (K Doses) by Countries (2012-2017)
Table Africa Influenza Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Influenza Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Influenza Vaccine Sales Market Share by Countries in 2016
Table Africa Influenza Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Africa Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Influenza Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Nigeria Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Egypt Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Algeria Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Table GSK Influenza Vaccine Basic Information List
Table GSK Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure GSK Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure GSK Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure GSK Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Sinovac Influenza Vaccine Basic Information List
Table Sinovac Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sinovac Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Sinovac Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sinovac Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Changsheng Influenza Vaccine Basic Information List
Table Changsheng Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Changsheng Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Changsheng Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Changsheng Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table CCBIO Influenza Vaccine Basic Information List
Table CCBIO Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure CCBIO Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure CCBIO Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure CCBIO Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Aleph Biomedical Influenza Vaccine Basic Information List
Table Aleph Biomedical Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Aleph Biomedical Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Aleph Biomedical Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Aleph Biomedical Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Sanofi Influenza Vaccine Basic Information List
Table Sanofi Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sanofi Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Sanofi Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sanofi Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Lanzhou Institute Of Biological Product Influenza Vaccine Basic Information List
Table Lanzhou Institute Of Biological Product Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Siobp Influenza Vaccine Basic Information List
Table Siobp Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Siobp Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Siobp Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Siobp Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Hualan Bio Influenza Vaccine Basic Information List
Table Hualan Bio Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Hualan Bio Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Hualan Bio Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Hualan Bio Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Tianyuan Bio-Pharma Influenza Vaccine Basic Information List
Table Tianyuan Bio-Pharma Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Tianyuan Bio-Pharma Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Tianyuan Bio-Pharma Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Tianyuan Bio-Pharma Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Vaxtec Influenza Vaccine Basic Information List
Table Hissen Influenza Vaccine Basic Information List
Table Abbott Influenza Vaccine Basic Information List
Table Novartis Influenza Vaccine Basic Information List
Table Tasly&Jenner Influenza Vaccine Basic Information List
Table Tiantan Influenza Vaccine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Influenza Vaccine
Figure Manufacturing Process Analysis of Influenza Vaccine
Figure Influenza Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Influenza Vaccine Major Manufacturers in 2016
Table Major Buyers of Influenza Vaccine
Table Distributors/Traders List
Figure EMEA Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Influenza Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Influenza Vaccine Price (USD/Dose) and Trend Forecast (2017-2022)
Table EMEA Influenza Vaccine Sales (K Doses) Forecast by Region (2017-2022)
Figure EMEA Influenza Vaccine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Influenza Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Influenza Vaccine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Influenza Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Europe Influenza Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Influenza Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Influenza Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Influenza Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Middle East Influenza Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Influenza Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Influenza Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Influenza Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Africa Influenza Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Influenza Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Influenza Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Influenza Vaccine Sales (K Doses) Forecast by Type (2017-2022)
Figure EMEA Influenza Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Influenza Vaccine Sales (K Doses) Forecast by Application (2017-2022)
Figure EMEA Influenza Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top